Abu Dhabi, UAE: Burjeel Holdings PLC (BURJEEL), a top-tier healthcare provider in MENA, announced robust Q3’24 financial results, marking 14% revenue growth and a 12% rise in patient footfall. Listed on the Abu Dhabi Securities Exchange, Burjeel’s performance underscores its success in expanding high-demand services across the UAE and Saudi Arabia.
Key Highlights:
- Strong Revenue and Market Penetration: Revenue in Q3’24 grew by 14% to AED 3.7 billion, driven by increased demand across oncology, orthopedics, pediatrics, and women’s healthcare. Total patient visits reached 4.8 million in 9M’24, a result of Burjeel’s extensive network and specialized care.
- Strategic Expansion: Burjeel launched the UAE’s largest fertility center, Trust Fertility Clinic, enhancing services from IVF to pediatric care, providing a seamless experience for women from conception to delivery. Its partnership with Abu Dhabi Stem Cells Center now offers an advanced ecosystem for bone marrow transplants, regenerative medicine, and cellular therapy, catering to blood cancers and genetic conditions. In Saudi Arabia, Burjeel opened 11 new PhysioTherabia centers, aligning with Vision 2030 goals, and signed deals with major insurers.
- Enhanced Specialty Services: Burjeel saw 26 successful multi-organ transplants, maintaining a 100% success rate, which reinforces its leading role in complex care. The Burjeel Cancer Institute at Burjeel Medical City (BMC) saw high demand, completing over 11,000 oncology procedures and expanding radiation services by 33% YoY.
- Financial Performance: Q3’24 EBITDA rose to AED 273 million, with a 22% margin when excluding new assets. Net profit before taxes increased 9.8% to AED 151 million in Q3, supported by strategic investments and increased bed occupancy to 66%. New facilities in the UAE and KSA added substantial growth, including 28 PhysioTherabia centers and multiple day surgery centers, broadening Burjeel’s high-yield asset base.
Future Outlook: Burjeel aims to leverage strong regional growth trends, with plans for continued expansion in high-growth specialties, enhanced oncology services, and targeted medical tourism programs. The Group’s network of community clinics and advanced cancer care centers positions it to serve rising patient volumes, boost long-term profitability, and strengthen its leadership across MENA’s healthcare sector.
